As of 2024-12-11, the Relative Valuation of Profound Medical Corp (PRN.TO) is (57.94) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 10.66 CAD, the upside of Profound Medical Corp based on Relative Valuation is -643.5%.
The range of the Relative Valuation is (60.70) - (54.46) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 33.7x - 44.0x | 37.2x |
| Forward P/E multiples | 24.9x - 30.2x | 27.1x |
| Fair Price | (60.70) - (54.46) | (57.94) |
| Upside | -669.4% - -610.9% | -643.5% |
| Date | P/E |
| 2024-12-06 | -8.37 |
| 2024-12-05 | -8.84 |
| 2024-12-04 | -9.07 |
| 2024-12-03 | -9.20 |
| 2024-12-02 | -9.19 |
| 2024-11-29 | -8.99 |
| 2024-11-28 | -8.54 |
| 2024-11-27 | -8.83 |
| 2024-11-26 | -8.52 |
| 2024-11-25 | -8.32 |
| 2024-11-22 | -8.34 |
| 2024-11-21 | -8.29 |
| 2024-11-20 | -8.41 |
| 2024-11-19 | -8.53 |
| 2024-11-18 | -8.70 |
| 2024-11-15 | -8.66 |
| 2024-11-14 | -8.88 |
| 2024-11-13 | -8.83 |
| 2024-11-12 | -8.89 |
| 2024-11-11 | -8.97 |
| 2024-11-08 | -9.41 |
| 2024-11-07 | -9.70 |
| 2024-11-06 | -8.80 |
| 2024-11-05 | -8.59 |
| 2024-11-04 | -8.92 |
| 2024-11-01 | -8.09 |
| 2024-10-31 | -7.97 |
| 2024-10-30 | -8.16 |
| 2024-10-29 | -8.08 |
| 2024-10-28 | -8.20 |
| 2024-10-25 | -7.93 |
| 2024-10-24 | -7.84 |
| 2024-10-23 | -7.86 |
| 2024-10-22 | -8.09 |
| 2024-10-21 | -8.11 |
| 2024-10-18 | -8.45 |
| 2024-10-17 | -8.40 |
| 2024-10-16 | -8.29 |
| 2024-10-15 | -8.29 |
| 2024-10-11 | -8.21 |
| 2024-10-10 | -8.08 |
| 2024-10-09 | -8.17 |
| 2024-10-08 | -8.27 |
| 2024-10-07 | -8.15 |
| 2024-10-04 | -8.39 |
| 2024-10-03 | -8.46 |
| 2024-10-02 | -8.66 |
| 2024-10-01 | -8.44 |
| 2024-09-30 | -8.45 |
| 2024-09-27 | -8.43 |